AstraZeneca News The Fly AstraZeneca announces results from CAPItello-281 trial 9d ago AZN The Fly AstraZeneca’s Truqap combo demonstrated statistically significant improvement 9d ago AZN The Fly AstraZeneca upgraded to Neutral from Sell at UBS ...
“We have a plan. We have very concrete cities, very [concrete] directions where we go. I can’t share all the details but we have some slow steps forward on the south, also we have steps on the east,” Zelensky stated. While largely avoiding naming any exact locations where such acti...
The company will share a Spotlight Theater Presentation: The Orchestrated Immune Response: Dynamic Forces Guiding Cancer Immunity, introducing a novel framework for understanding the role of the immune system in cancer, with the potential to reshape the way scientists develop medicines to counteract tumo...
You can see the complete list of today’s Zacks #1 Rank stocks here. In the past 60 days, estimates for Arcturus Therapeutics’ 2024 loss per share have improved from $4.39 to $2.60. Estimates for 2025 have improved from a loss of 45 cents to earnings of 21 cents per share during the...
AstraZeneca is commencing today, through a subsidiary, a tender offer to purchase all outstanding shares of CinCor Pharma, Inc. (CinCor), for $26 per share in cash at closing, plus a non-tradable contingent value right of $10 per share in cash payable up
| DelveInsight News provided by Share this article Share toX The market for complement inhibitors is expected to grow significantly in the coming years. Since the launch of SOLIRIS and ULTOMIRIS, the complement inhibitor market has seen a lot of traction, and many companies are now developing no...
Yes, sure. So I think, obviously, you're aware of the PDUFA date for Dato-DXd and our experience with the announcement of advisory committees is that, that can happen at any point during the review period. So -- and as I said, I don't have any updates to share with you today on...
As a trial of AstraZeneca's Vaxzevria vaccine on children between the ages of 6 and 17 has been paused, a third vaccine – Moderna – is being used in the UK as of today. The UK has bought 17 million doses of the Moderna jab, enough for 8.5 million peop...
Latest NewsAll Times Eastern 11:28aU.S. economy poised to dominate for the next 20 years — at the cost of growing inequality, economist says 11:28aBarron'sThese Stocks Are Moving the Most Today: Tesla, MicroStrategy, Synopsys, SentinelOne, AeroVironment, American Airlines, Verint, and More...
And then scale up to billions of doses when we know today the biggest manufacturer has only got a capacity of a billion doses per year across all their vaccines," said the AstraZeneca CEO. Earlier this month, Pfizer said vaccine shipments from its Puurs, Belgium plant...